All this negativity about potentially falling back to 1 cent. That is akin to saying to the recent IDMC observation of the efficacy and safety of Her-Vaxx that they were wrong. That all those of years of their experience were wasted and useless. I mean seriously?!!! And as LC herself has said before, Her-Vaxx is targeting the equivalent market of Herceptin and other biosims. That market alone is worth billions annually.
With the IDMC observation, I dare say the chances of failure now is very near to zero. And with that, the current valuation of IMU based on Her-Vaxx alone is still short around 100% from here.
All in my humble opinion of course. And I rather like to trust the experts more. And don't forget, this sort of recommendation by the IDMC is a once in a 10,000 events. Very rare.
IMU Price at posting:
31.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)